COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
An estimated 68% of U.S. adults intended to receive a COVID-19 vaccine when surveyed by the Centers for Disease Control and Prevention in December, up from 61.9% in September.
The Food and Drug Administration issued updated guidance on using ventilator splitters to support more than one patient when other options are unavailable.
Lesbian, gay and bisexual persons in the U.S. have higher self-reported prevalence of several underlying health conditions associated with severe COVID-19 outcomes, compared to heterosexual persons, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration revised and reissued its emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19.
Between March 22 and Oct. 17, 2020, weekly COVID-19-associated hospitalization rates reported by 10 COVID-19-Associated Hospitalization Surveillance Network sites declined by 5.5 percentage points for adults under age 65 after states began mandating the use of facemasks, according to a report …
The Food and Drug Administration cautioned health care providers against using compounded remdesivir drug products due to the potential for patient exposure to substandard or adulterated products.
The Food and Drug Administration announced that its Vaccines and Related Biological Products Advisory Committee will convene Feb. 26 to discuss the emergency use authorization application by Johnson & Johnson and Janssen Biotech, Inc. for its investigational single-dose COVID-19 vaccine…
About 12. 9 million people received at least one dose of the Pfizer or Moderna COVID-19 vaccines between Dec. 14 and Jan. 14, the first month of the U.S. COVID-19 vaccination program, the Centers for Disease Control and Prevention reported.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
The Centers for Medicare & Medicaid Services (CMS) today released updated guidance putting in place certain limitations on the hospital survey process, including limiting onsite surveys to immediate jeopardy complaint allegations. The limitations will remain in effect for 30 days with the…